Recent news on

Ariad and Amgen in battle over biotech patent  -  Apr 18, 2007
BiopharmaReporter.com,In the Lilly case last May, Ariad alleged that Lilly's septic shock drug Xigris (drotrecogin alfa) and Evista (raloxifene), a treatment for osteoporosis,

Lilly Reports Strong First-Quarter Results; Raises Full-Year Sales ...  -  Apr 16, 2007
Earthtimes.org...or OFC, Lilly) Xigris(R) (drotrecogin alfa (activated), Lilly) Yentreve(R) (duloxetine hydrochloride, Lilly) Zyprexa(R) (olanzapine, Lilly) Eli Lilly

Lilly Plans New Clinical Trial of Xigris(R)  -  Mar 8, 2007
Drug Newswire (press release),In patients with multiple organ dysfunction, mortality rates were 26.5 percent among drotrecogin alfa (activated)-treated patients vs.

Lilly Plans New Clinical Trial of Xigris(R)  -  Feb 26, 2007
Earthtimes.org26 -- Eli Lilly and Company today announced plans for a new clinical study of Xigris(R) (drotrecogin alfa [activated]). The trial is designed to help

Management of Sepsis  -  Mar 16, 2007
New England Journal of Medicine (subscription),In the Administration of Drotrecogin Alfa (Activated) in Early Stage Severe Sepsis (ADDRESS) trial, 2 post hoc analysis of the subgroup of patients who had

Lilly Announces 2006 Adjusted EPS of $3.18 Excluding Charges and ...  -  Jan 31, 2007
Earthtimes.org...or OFC, Lilly) Xigris(R) (drotrecogin alfa (activated), Lilly) Yentreve(R) (duloxetine hydrochloride, Lilly) Zyprexa(R) (olanzapine, Lilly) Eli Lilly

Lilly Announces 2006 Adjusted EPS of $3.18 Excluding Charges and ...  -  Jan 31, 2007
Yahoo! News (press release)Lilly) Strattera® (atomoxetine hydrochloride, Lilly) Symbyax® (olanzapine fluoxetine combination, or OFC, Lilly) Xigris® (drotrecogin alfa (activated),

Health Canada Endorsed Important Safety Information on Xigris ...  -  Jan 3, 2007
DG News...prophylactic low-dose heparin is abruptly discontinued in patients to be started on Xigris® [drotrecogin alfa (activated)] therapy for severe sepsis.

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional